Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro.

[1]  S. Krauss,et al.  Tankyrases: Structure, Function and Therapeutic Implications in Cancer , 2014, Current pharmaceutical design.

[2]  M. K. Kim,et al.  Persistent telomere cohesion triggers a prolonged anaphase , 2014, Molecular biology of the cell.

[3]  H. Bregman,et al.  Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors. , 2013, Journal of medicinal chemistry.

[4]  T. Pihlajaniemi,et al.  para‐Substituted 2‐Phenyl‐3,4‐dihydroquinazolin‐4‐ones As Potent and Selective Tankyrase Inhibitors , 2013, ChemMedChem.

[5]  M. D. Lloyd,et al.  Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases. , 2013, ACS medicinal chemistry letters.

[6]  T. Pihlajaniemi,et al.  Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. , 2013, Journal of medicinal chemistry.

[7]  M. D. Lloyd,et al.  One-pot tandem Hurtley-retro-Claisen-cyclisation reactions in the synthesis of 3-substituted analogues of 5-aminoisoquinolin-1-one (5-AIQ), a water-soluble inhibitor of PARPs. , 2013, Bioorganic & medicinal chemistry.

[8]  D. Chin,et al.  Structure-efficiency relationship of [1,2,4]triazol-3-ylamines as novel nicotinamide isosteres that inhibit tankyrases. , 2013, Journal of medicinal chemistry.

[9]  D. Chin,et al.  Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor. , 2013, Journal of medicinal chemistry.

[10]  S. Krauss,et al.  Tankyrases as drug targets , 2013, The FEBS journal.

[11]  S. Krauss,et al.  A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth. , 2013, Cancer research.

[12]  A. Fallarero,et al.  Screening and structural analysis of flavones inhibiting tankyrases. , 2013, Journal of medicinal chemistry.

[13]  G. Drewes,et al.  Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor. , 2013, Journal of medicinal chemistry.

[14]  E. Jho,et al.  Wnt/β-catenin signalling: from plasma membrane to nucleus. , 2013, The Biochemical journal.

[15]  H. Bregman,et al.  Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket. , 2013, Journal of medicinal chemistry.

[16]  R. Moon,et al.  WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.

[17]  H. Dinh,et al.  A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. , 2012, Cancer research.

[18]  B. Jiang,et al.  Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas , 2012, Journal of Clinical Neuroscience.

[19]  L. Lehtiö,et al.  Structural basis of selective inhibition of human tankyrases. , 2012, Journal of medicinal chemistry.

[20]  Y. Yamauchi,et al.  Herpes Simplex Virus Requires Poly(ADP-Ribose) Polymerase Activity for Efficient Replication and Induces Extracellular Signal-Related Kinase-Dependent Phosphorylation and ICP0-Dependent Nuclear Localization of Tankyrase 1 , 2011, Journal of Virology.

[21]  N. Curtin,et al.  The role of PARP in DNA repair and its therapeutic exploitation , 2011, British Journal of Cancer.

[22]  M. D. Lloyd,et al.  5-Benzamidoisoquinolin-1-ones and 5-(ω-carboxyalkyl)isoquinolin-1-ones as isoform-selective inhibitors of poly(ADP-ribose) polymerase 2 (PARP-2). , 2011, Journal of medicinal chemistry.

[23]  M. Blasco,et al.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins , 2011, Nature Reviews Cancer.

[24]  M. D. Lloyd,et al.  Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitor. , 2011, Organic & biomolecular chemistry.

[25]  Sandy Chang.  The telomere protein tankyrase 1 regulates DNA damage responses at telomeres , 2010, Aging.

[26]  Natalia Markova,et al.  Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor. , 2010, Journal of medicinal chemistry.

[27]  D. Ferraris,et al.  Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. , 2010, Journal of medicinal chemistry.

[28]  R. DePinho,et al.  Linking functional decline of telomeres, mitochondria and stem cells during ageing , 2010, Nature.

[29]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[30]  M. Threadgill,et al.  Effect of Poly (ADP-ribose) Polymerase-1 Inhibition on the Proliferation of Murine Colon Carcinoma CT26 Cells , 2009, Pathology & Oncology Research.

[31]  M. D. Lloyd,et al.  4-Substituted 5-nitroisoquinolin-1-ones from intramolecular Pd-catalysed reaction of N-(2-alkenyl)-2-halo-3-nitrobenzamides , 2009 .

[32]  J. Karbach,et al.  Human tankyrases are aberrantly expressed in colon tumors and contain multiple epitopes that induce humoral and cellular immune responses in cancer patients , 2008, Cancer Immunology, Immunotherapy.

[33]  J. Weigelt,et al.  Zinc binding catalytic domain of human tankyrase 1. , 2008, Journal of molecular biology.

[34]  M. Threadgill,et al.  Formation of 3-aryl-5-nitroisocoumarins from 5-nitroisocoumarins and aromatic acyl chlorides under Friedel-Crafts conditions. , 2007, The Journal of organic chemistry.

[35]  T. Dawson,et al.  Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma , 2007, Brain Research.

[36]  F. Cianchi,et al.  Distribution of Tankyrase-1 mRNA expression in colon cancer and its prospective correlation with progression stage. , 2006, Oncology reports.

[37]  Tsung-Yin J. Yeh,et al.  Mitotic phosphorylation of tankyrase, a PARP that promotes spindle assembly, by GSK3. , 2006, Biochemical and biophysical research communications.

[38]  M. Threadgill,et al.  Reductive cyclisation of 2-cyanomethyl-3-nitrobenzoates , 2006 .

[39]  M. Threadgill,et al.  5-Nitroisocoumarins from tandem Castro–Stephens coupling—6-endo-dig cyclisation of 2-iodo-3-nitrobenzoic acid and arylethynes and ring-closure of methyl 2-alkynyl-3-nitrobenzoates with electrophiles , 2006 .

[40]  J. Boultwood,et al.  hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia , 2006, Leukemia.

[41]  H. Seimiya.  The telomeric PARP, tankyrases, as targets for cancer therapy , 2006, British Journal of Cancer.

[42]  T. Mitchison,et al.  Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function , 2005, Nature Cell Biology.

[43]  Susan Smith,et al.  NuMA is a major acceptor of poly(ADP-ribosyl)ation by tankyrase 1 in mitosis. , 2005, The Biochemical journal.

[44]  E. Mazzon,et al.  Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and the Development of Bleomycin-Induced Lung Injury , 2005, Journal of Pharmacology and Experimental Therapeutics.

[45]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.

[46]  N. Patel,et al.  Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma , 2005, Journal of Pharmacology and Experimental Therapeutics.

[47]  S. Bianchi,et al.  Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. , 2004, Cancer letters.

[48]  Susan Smith,et al.  Resolution of Sister Telomere Association Is Required for Progression Through Mitosis , 2004, Science.

[49]  T. Tsuruo,et al.  Functional Subdomain in the Ankyrin Domain of Tankyrase 1 Required for Poly(ADP-Ribosyl)ation of TRF1 and Telomere Elongation , 2004, Molecular and Cellular Biology.

[50]  S. Cuzzocrea,et al.  5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion. , 2004, Kidney international.

[51]  H. Lodish,et al.  Tankyrase-2 oligomerizes with tankyrase-1 and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP (insulin-responsive aminopeptidase). , 2002, The Biochemical journal.

[52]  S. Hagl,et al.  Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation , 2002, Circulation research.

[53]  Brandoch D. Cook,et al.  Role for the Related Poly(ADP-Ribose) Polymerases Tankyrase 1 and 2 at Human Telomeres , 2002, Molecular and Cellular Biology.

[54]  G. Morin,et al.  TANK2, a New TRF1-associated Poly(ADP-ribose) Polymerase, Causes Rapid Induction of Cell Death upon Overexpression* , 2001, The Journal of Biological Chemistry.

[55]  James A. Wright,et al.  Effects of 5‐aminoisoquinolinone, a water‐soluble, potent inhibitor of the activity of poly (ADP‐ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock , 2000, British journal of pharmacology.

[56]  T. Lange,et al.  Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. , 1999, Journal of cell science.

[57]  A. Klingelhutz.  The roles of telomeres and telomerase in cellular immortalization and the development of cancer. , 1999, Anticancer research.

[58]  T. Lange,et al.  Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. , 1998, Science.

[59]  W. Cho,et al.  Synthesis and biological evaluation of 3-arylisoquinolines as antitumor agents. , 1998, Bioorganic & medicinal chemistry letters.

[60]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[61]  D. Broccoli,et al.  Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2 , 1997, Nature Genetics.

[62]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[63]  R. Tyrrell,et al.  Quantitative differences in host cell reactivation of ultraviolet-damaged virus in human skin fibroblasts and epidermal keratinocytes cultured from the same foreskin biopsy. , 1986, Cancer research.

[64]  G. Poindexter.  Convenient preparation of 3-substituted 1(2H)-isoquinolinones , 1982 .

[65]  T. Orfeo,et al.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.

[66]  S. Gelmini,et al.  Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience , 2007, Clinical chemistry and laboratory medicine.

[67]  A. Kuimov,et al.  Immunohistochemical detection of tankyrase 2 in human breast tumors and normal renal tissue , 2005, Cell and Tissue Research.